Top Markets
Coin of the day
Vincerx Pharma, Inc. Vincerx Pharma, Inc.

Vincerx Pharma, Inc.

VINC
Ранг среди акций #40889
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical... Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
Цена акции
$0.0127
Последняя синхронизация: 2026-08-12
Рыночная капитализация
$66.48K
Изменение (1 день)
-2.31%
Изменение (1 год)
-67.44%
Страна
US
Торговля Vincerx Pharma, Inc. (VINC)

Категория

Коэффициент P/B для Vincerx Pharma, Inc. (VINC)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Vincerx Pharma, Inc., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Vincerx Pharma, Inc. с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE